FDA Adverse Event Injury Summary report: N

UNKNOWN IMPLANTABLE NEUROSTIMULATOR

MDR report key: 3181553 · Received June 21, 2013

Report

Report Number
3007566237-2013-02045
Event Type
Injury
Date Received
June 21, 2013
Date of Event
April 17, 2013
Report Date
May 29, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE ACTUAL EVENT DATES WERE NOT PROVIDED. THIS DATE IS BASED ON THE DATE OF PUBLICATION OF THE ARTICLE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. CONCOMITANT PRODUCTS: PRODUCT ID NEU_UNKNOWN_EXT, LOT# UNKNOWN, PRODUCT TYPE EXTENSION; PRODUCT ID NEU_ UNKNOWN_LEAD, LOT# UNKNOWN, PRODUCT TYPE LEAD. (B)(4).

Description of Event or Problem · 1

CHODAKIEWITZ, Y. G., BICALHO, G. V., CHODAKIEWITZ, J. W. MULTI-TARGET NEUROSTIMULATION FOR ADEQUATE LONG-TERM RELIEF OF NEUROPATHICAND NOCICEPTIVE CHRONIC PAIN COMPONENTS. SURGICAL NEUROLOGY INTERNATIONAL. 2013;4(SUPPL 3):S170-175. DOI: 10.4103/2152-7806.110676. SUMMARY: SUCCESSFUL TREATMENT OF CHRONIC PAIN FOR PATIENTS WITH FAILED BACK SURGERY SYNDROME CAN BE EXTREMELY COMPLICATED. THESEPATIENTS REQUIRE CAREFUL AND INDIVIDUALIZED CLINICAL ASSESSMENT, AS THEY OFTEN PRESENT WITH MIXED PAIN SYNDROMES THAT INVOLVE BOTH NEUROPATHIC AND NOCICEPTIVE COMPONENTS. THE DISTINCT TYPES OF PAIN INVOLVED IN SUCH CASES MAY REQUIRE COMBINED TREATMENTS FROM INDIVIDUAL INTERVENTIONS THAT ARE ANALGESICALLY INDEPENDENT AND SPECIFIC FOR EACH TYPE OF PAIN INVOLVED. NEUROMODULATION BY ELECTRIC STIMULATION AT APPROPRIATELY CHOSED TARGETS AND COMBINATIONS MAY BE AN IMPORTANT OPTION TO CONSIDER FOR SUCH PATIENTS. WE PRESENT A CASEOF COMBINED DEBILITATING AXIAL NOCICEPTIVE SPINAL PAIN AND BILATERAL NEUROPATHIC LEG PAIN IN A PATIENT AFTER 14 FAILED BACK OPERATIONS. A COMBINATION OF SPINAL CORD STIMULATION AND DEEP BRAIN STIMULATION IN THE PERIVENTRICULAR GRAY (PVG) HAVE SUCCESSFULLY PROVIDED THE PATIENT WITH COMPLETE RELIEF OF BOTH COMPONENTS OF HIS CHRONIC PAIN CONDITION, AFTER ALL OTHER PAIN MANAGEMENT OPTIONS HAD BEEN EXHAUSTED. BY ALTERNATING ACTIVATION OF EACH IMPLANTED STIMULATOR SEPARATELY AND IN CONJUNCTION, WE WERE ABLE TO DEMONSTRATE A CLINICALLY INDEPENDENT ANALGESIC CHARACTER FOR EACH STIMULATION SYSTEM, EACH SPECIFIC TO A PARTICULAR TYPE OF PAIN. THE SCS PROVIDED COMPLETE RELIEF OF THE NEUROPATHIC PAIN COMPONENT WITHOUT AFFECTING THE NOCICEPTIVE COMPONENT AT ALL. IN COMBINATION, THERE WAS COMPLETE RELIEF OF THE TOTAL CHRONIC PAIN CONDITION. THERE APPEARED TO BE NO OVERLAPPING OR SYNERGISTIC EFFECT BETWEEN THE TWO NEUROMODULATION SYSTEMS IN THE PATIENT. THE PATIENT HAS HAD PROLONGED COMPLETE RELIEF FROM HIS CHRONIC PAIN CONDITION WITH THE COMBINED NEUROMODULATION INTERVENTION OVER 22 YEARS OF FOLLOW-UP. REPORTED EVENT: PATIENT HAD WIRE-CONNECTOR REVISION AFTER SECOND MOTOR VEHICLE ACCIDENT. FURTHER INFORMATION HAS BEEN REQUESTED; A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
282220 UNKNOWN IMPLANTABLE NEUROSTIMULATOR STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR

Patients

Seq Age Sex Outcome Treatment
1 00046 YR Required Intervention